Signal #143372 · SEC 8-K

$ONC SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $ONC filing catalyst

Why did $ONC trigger an AI stock catalyst alert?

$ONC triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +7.5/10). Headline: BeOne Medicines Reports Q3 2026: Revenue +34% to $1.9B, Raises Guidance. Key points: - Total global Q3 revenues rose 34% YoY to $1.9B, led by BRUKINSA sales of $1.4B (+34% YoY). - GAAP diluted EPS reached $3.28 (vs $1.09 YoY); Non-GAAP diluted EPS at $4.59. - Management raised total revenue guidance for full-year 2026.

How did $ONC stock react after the SEC filing?

After the SEC 8-K for $ONC, observed market reaction: T0 price $377.78. Past moves do not guarantee future results.

Where can I get real-time $ONC SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $ONC via Telegram and the VIP Web Terminal from €10/month.

$ONC

$ONC – BeOne Medicines Reports Q3 2026: Revenue +34% to $1.9B, Raises Guidance

BeOne Medicines Ltd.

2026-11-05 00:00:00 UTC · SEC 8-K · All $ONC

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+7.5 / 10)

Total global Q3 revenues rose 34% YoY to $1.9B, led by BRUKINSA sales of $1.4B (+34% YoY).
GAAP diluted EPS reached $3.28 (vs $1.09 YoY); Non-GAAP diluted EPS at $4.59.
Management raised total revenue guidance for full-year 2026.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →